Abstract

A key advantage of nanomaterials for biomedical applications is their ability to feature multiple small reporter groups (multimodality), or combinations of reporter groups and therapeutic agents (multifunctionality), while being targeted to cell surface receptors. Here a facile combination of techniques for the syntheses of multimodal, targeted nanoparticles (NPs) is presented, whereby heat-induced-radiolabeling (HIR) labels NPs with radiometals and so-called click chemistry is used to attach bioactive groups to the NP surface. Click-reactive alkyne or azide groups were first attached to the nonradioactive clinical Feraheme (FH) NPs. Resulting “Alkyne-FH” and “Azide-FH” intermediates, like the parent NP, tolerated 89Zr labeling by the HIR method previously described. Subsequently, biomolecules were quickly conjugated to the radioactive NPs by either copper-catalyzed or copper-free click reactions with high efficiency. Synthesis of the Alkyne-FH or Azide-FH intermediates, followed by HIR and then by click reactions for biomolecule attachment, provides a simple and potentially general path for the synthesis of multimodal, multifunctional, and targeted NPs for biomedical applications.

Highlights

  • The value of multimodal or multifunctional nanomaterials has been discussed[1] and been the subject of recent comprehensive reviews.[2, 3] Here we provide a facile and general approach to the design of targeted, theranostic nanoparticles (NPs) whereby Feraheme (FH) nanoparticles (NPs) undergo a heat induced radiolabeling (HIR) for detection by nuclear techniques, followed by biomolecule attachment to the NP surface using mild click chemistry reactions

  • Though one of several chelator-free methods for radiolabeling nanomaterials,[6] HIR is unique in its ability to label a NP drug with any of three cations used in positron emission tomography (PET) or single photon emission computed tomography (SPECT) (64Cu2 +, 111In3+ or 89Zr4+).[4, 5]

  • These procedures yield magnetic resonance imaging (MRI) detectable FH NPs that can be labeled with therapeutic radiometals like 111In3+

Read more

Summary

Introduction

The value of multimodal (detectable more than one modality) or multifunctional (therapeutic and diagnostic) nanomaterials has been discussed[1] and been the subject of recent comprehensive reviews.[2, 3] Here we provide a facile and general approach to the design of targeted, theranostic nanoparticles (NPs) whereby Feraheme (FH) nanoparticles (NPs) undergo a heat induced radiolabeling (HIR) for detection by nuclear techniques, followed by biomolecule attachment to the NP surface using mild click chemistry reactions. The HIR technique employs heat (120 ̊C, 2 hr) to bind cations to the surface of 5 nm iron oxides.[4, 5]. Though one of several chelator-free methods for radiolabeling nanomaterials,[6] HIR is unique in its ability to label a NP drug with any of three cations used in PET or SPECT (64Cu2 +, 111In3+ or 89Zr4+).[4, 5] These procedures yield MRI detectable FH NPs that can be labeled with therapeutic radiometals like 111In3+

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call